Globavir Biosciences
(Private)

Developing life-saving technologies for cancer and the diagnosis and treatment of some of the world’s most deadly viral diseases. To complement its world-class dengue diagnostic assays, Globavir is also developing GBV006, a powerful combination drug therapy, for the treatment of dengue fever.



SIGN UP FOR EMAIL ALERTS

BE THE FIRST TO RECEIVE BREAKING NEWS

Latest Investor Presentation

Latest Investor Presentation

 View Full Presentation |  Download

Ask the CEO



Receive Private Email Alerts

*By entering your information you agree to our privacy policy.


"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President The NASDAQ Stock Market